Carl Zeiss Meditec : Presentation AGM26 March 2026

About this update from Carl Zeiss Meditec Ag

‌Welcome Annual General Meeting of Carl Zeiss Meditec AG Thursday, March 26, 2026 ‌2,227.6 million Euro revenue in fiscal year 2024/25 ‌257.7 Mio. Euro EBITA* in fiscal year 2024/25 +4% EBITA*-margin in fiscal year 2024/25 *Earnings before interest, taxes and amortization of intangible assets from the purchase price allocation ‌467.0 million euros in revenue in the first quarter of 2025/26 -4.8% compared to the previous year 8.1 mio. euros in EBITA ‌CIRRUS ® PathFinder TM AI-based deep learning tool supports OCT interpretation in ophthalmic diagnostics CONVIVO ® In Vivo Pathology Suite Provides real-time information on tissue microstructure through consultations based on digital images ‌Our commercial strategy focuses on delivering value to customers worldwide: We understand local needs, develop tailored offerings, and scale them efficiently - to drive sustainable growth and build long-term customer relationships. Magnus Reibenspiess Chief Commercial Officer ‌KINEVO ® 900 S Further development of the successful ZEISS KINEVO 900 platform PENTERO ® 800 S ZEISS PENTERO platform redesigned for the digital world ‌ILM-Blue ® by DORC Vital dye for staining the inner limiting membrane of the retina Dr. Ananth Sastry, MD, Cleveland Clinic, Ohio ‌AT LISA ® 809 In February 2026, ZEISS received a license in China for the new model of this bifocal intraocular lens. ‌ ©Deutscher Zukunftspreis / Ansgar Pudenz ©Deutscher Zukunftspreis / Ansgar Pudenz ZEISS EUV Lithographie Winner of Deutscher Zukunftspreis 2020 ZEISS KINEVO 900 Circle of the Best Deutscher Zukunftspreis 2020 ‌ ©Deutscher Zukunftspreis / Ansgar Pudenz ©Deutscher Zukunftspreis / Ansgar Pudenz ZEISS Lattice Lightsheet 7 Winner of Deutschen Zukunftspreis 2022 ZEISS VisuMax & ZEISS SMILE Circle of the Best Deutschen Zukunftspreis 2025 ‌0.55 Euro dividend per share ‌Thank you!

View stock analysis, news, and events for Carl Zeiss Meditec Ag